Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic Application.

Shen C, Iskenderian A, Lundberg D, He T, Palmieri K, Crooker R, Deng Q, Traylor M, Gu S, Rong H, Ehmann D, Pescatore B, Strack-Logue B, Romashko A, Baviello G, Gill J, Zhang B, Meiyappan M, Pan C, Norton AW.

J Pharmacol Exp Ther. 2018 May 11. pii: jpet.118.248195. doi: 10.1124/jpet.118.248195. [Epub ahead of print]

2.

Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.

Peterson SM, Iskenderian A, Cook L, Romashko A, Tobin K, Jones M, Norton A, Gómez-Yafal A, Heartlein MW, Concino MF, Liaw L, Martini PG.

BMC Cancer. 2010 Aug 13;10:427. doi: 10.1186/1471-2407-10-427.

3.

The acidic domain of pUL37x1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions.

Colberg-Poley AM, Huang L, Soltero VE, Iskenderian AC, Schumacher RF, Anders DG.

Virology. 1998 Jul 5;246(2):400-8.

4.
5.

Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection.

Kerry JA, Priddy MA, Jervey TY, Kohler CP, Staley TL, Vanson CD, Jones TR, Iskenderian AC, Anders DG, Stenberg RM.

J Virol. 1996 Jan;70(1):373-82.

6.

Successful emergency operation for hydatid disease of the left ventricle.

al-Naaman Y, Iskenderian AS, al-Omeri MM, al-Naama MR, Barlow D.

J Cardiovasc Surg (Torino). 1973 Sep-Oct;14(5):564-8. No abstract available.

PMID:
4767450

Supplemental Content

Loading ...
Support Center